Christine Iacobuzio-donahue, MD | |
600 N Wolfe St, Baltimore, MD 21287-0005 | |
(410) 955-2660 | |
Not Available |
Full Name | Christine Iacobuzio-donahue |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 600 N Wolfe St, Baltimore, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689613317 | NPI | - | NPPES |
400786700 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | D58453 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christine Iacobuzio-donahue, MD Po Box 64478, Baltimore, MD 21264-4478 Ph: (410) 955-2660 | Christine Iacobuzio-donahue, MD 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 955-2660 |
News Archive
Accuray Incorporated, the premier radiation oncology company, announced today that outcome data on intermediate risk prostate cancer patients treated with CyberKnife Prostate SBRT was presented at the American Urological Association Meeting (AUA) 2012 held in Atlanta, Ga.
If Thanksgiving makes you wince at the thought of impending heartburn pain, you are probably not alone. But if you experience heartburn more than twice a week despite over-the-counter treatments, a Jefferson expert wants you to check with your doctor. Gastroesophageal Reflux Disease (GERD) Awareness Week is observed each year during the week of Thanksgiving, a fitting time as Americans prepare to indulge in the holiday season.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Incidence of intrahepatic cholangiocarcinoma (ICC) is increasing worldwide and its prognosis is very poor. Thus, further studies on its clinical characteristics for early detection and on surgical treatment for better prognosis are urgently needed.
› Verified 7 days ago
Serena Maria Bagnasco, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-955-2660 | |
Dr. Adeboye Oluwaseyi Osunkoya, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway, Johns Hopkins Pathology , Weinberg Room 2242, Baltimore, MD 21231 Phone: 405-808-5361 | |
Michael T. O'malley, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-644-4379 Fax: 410-644-4325 | |
Michael Edward Kallen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway St, Baltimore, MD 21287 Phone: 410-955-3580 Fax: 410-614-1287 | |
Deyin Xing, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 North Broadway, Weinberg 2268, Baltimore, MD 21231 Phone: 410-955-3580 Fax: 410-614-1287 | |
Matthew Grant Gabrielson, Pathology Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-3980 | |
Robert A. Palermo, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Baltimore, MD 21204 Phone: 443-849-2257 Fax: 443-849-3016 |